BDBM257508 US9505736, (1S,2S,3S)-2-(4-(2-Cyclopropyloxazol- 5-yl)phenyl)-1-fluoro-N-hydroxy-3- phenylcyclopropanecarboxamide
SMILES: ONC(=O)[C@]1(F)[C@@H]([C@H]1c1ccc(cc1)-c1cnc(o1)C1CC1)c1ccccc1
InChI Key: InChIKey=FZFWDBNDYFWRRQ-KNKQGSTJSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histone deacetylase 4 [648-729,745-1057] (Homo sapiens (Human)) | BDBM257508 (US9505736, (1S,2S,3S)-2-(4-(2-Cyclopropyloxazol- 5...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 8.0 | 25 |
CHDI Foundation, Inc. US Patent | Assay Description The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati... | US Patent US9505736 (2016) BindingDB Entry DOI: 10.7270/Q2T152KR | |||||||||||
More data for this Ligand-Target Pair |